Polo‑like kinase 1 selective inhibitor BI2536 (dihydropteridinone) disrupts centrosome homeostasis via ATM‑ERK cascade in adrenocortical carcinoma. [PDF]
Oncol Rep, 2023 Lin RC +5 more
europepmc +1 more source
Functional and structural impacts of oncogenic missense variants on human polo-like kinase 1 protein. [PDF]
Front BioinformMunieswaran G, Manickam V.
europepmc +1 more source
Polo-like kinase 1 promotes Cdc42-induced actin polymerization for asymmetric division in oocytes. [PDF]
Open Biol, 2023 Yuen WS +5 more
europepmc +1 more source
Polo-Like Kinase 1 Phosphorylation Tunes the Functional Viscoelastic Properties of the Centrosome Scaffold. [PDF]
Adv Sci (Weinh)Amato M +5 more
europepmc +1 more source
Structural Basis for Variations in Polo-like Kinase 1 Conformation and Intracellular Stability Induced by ATP-Competitive and Novel Noncompetitive Abbapolin Inhibitors. [PDF]
ACS Chem Biol, 2023 Chapagai D +3 more
europepmc +1 more source
A Mouse Model of Partial Pancreas Agenesis Induced by Polo-like kinase 1 Mutation. [PDF]
FASEB JChen X, Jia Z, Kuang S.
europepmc +1 more source
Polo-like kinase 1 is related with malignant characteristics and inhibits macrophages infiltration in glioma. [PDF]
Front Immunol, 2022 Luo L +11 more
europepmc +1 more source
Aurora kinases; polo-like kinase 1 (PLK1; STPK13) [PDF]
Science-Business eXchange, 2013 openaire +1 more source
Polo-Like Kinase 1 Expression in Colorectal Cancer: Association With RAS Mutations. [PDF]
Cancer SciTanaka Y +9 more
europepmc +1 more source
Identification of polo-like kinase 1 as a therapeutic target in murine lupus. [PDF]
Clin Transl Immunology, 2022 Li Y +6 more
europepmc +1 more source